Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100506730 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
PAFAH1B1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDHC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDZD8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM97 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SDK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKI55 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF4EBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIAPH3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CEP78 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM171B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TRIM24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRELID2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ORMDL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
REPS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on